首页 | 本学科首页   官方微博 | 高级检索  
   检索      


Pyrrolopyrimidine inhibitors of DNA gyrase B (GyrB) and topoisomerase IV (ParE). Part I: Structure guided discovery and optimization of dual targeting agents with potent,broad-spectrum enzymatic activity
Authors:Leslie W Tari  Michael Trzoss  Daniel C Bensen  Xiaoming Li  Zhiyong Chen  Thanh Lam  Junhu Zhang  Christopher J Creighton  Mark L Cunningham  Bryan Kwan  Mark Stidham  Karen J Shaw  Felice C Lightstone  Sergio E Wong  Toan B Nguyen  Jay Nix  John Finn
Institution:1. Trius Therapeutics, 6310 Nancy Ridge Dr., San Diego, CA 92121, USA;2. Lawrence Livermore National Laboratory, Physical and Life Sciences Directorate, Livermore, CA 94550, USA;3. Advanced Light Source, Beamline 4.2.2, 1 Cyclotron Rd., Berkeley, CA 94720, USA
Abstract:The bacterial topoisomerases DNA gyrase (GyrB) and topoisomerase IV (ParE) are essential enzymes that control the topological state of DNA during replication. The high degree of conservation in the ATP-binding pockets of these enzymes make them appealing targets for broad-spectrum inhibitor development. A pyrrolopyrimidine scaffold was identified from a pharmacophore-based fragment screen with optimization potential. Structural characterization of inhibitor complexes conducted using selected GyrB/ParE orthologs aided in the identification of important steric, dynamic and compositional differences in the ATP-binding pockets of the targets, enabling the design of highly potent pyrrolopyrimidine inhibitors with broad enzymatic spectrum and dual targeting activity.
Keywords:
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号